Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
CME Group is a financial data & stock exchanges business based in the US. CME Group shares (CME) are listed on the NASDAQ and all prices are listed in US Dollars. CME Group employs 3,480 staff and has a trailing 12-month revenue of around $4.9 billion.
Finder Award
SoFi Invest
Finder Award
eToro
Robinhood
| Latest market close | $176.66 |
|---|---|
| 52-week range | $161.33 - $245.26 |
| 50-day moving average | $174.38 |
| 200-day moving average | $190.68 |
| Wall St. target price | $200.82 |
| PE ratio | 24.0681 |
| Dividend yield | $3.9 (4.84%) |
| Earnings per share (TTM) | $7.34 |
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $176.66 from 2023-01-31
| 1 week (2023-01-21) | N/A |
|---|---|
| 1 month (2022-12-28) | N/A |
| 3 months (2022-10-28) | 1.09% |
| 6 months (2022-07-29) | -11.44% |
| 1 year (2022-02-01) | -23.86% |
|---|---|
| 2 years (2021-02-01) | -5.75% |
| 3 years (2020-01-31) | 217.11 |
| 5 years (2018-02-01) | 11.17% |
Valuing CME Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CME Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
CME Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 24x. In other words, CME Group shares trade at around 24x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
CME Group's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.6929. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into CME Group's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
CME Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.3 billion.
The EBITDA is a measure of a CME Group's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $4.9 billion |
|---|---|
| Operating margin TTM | 59.39% |
| Gross profit TTM | $4.7 billion |
| Return on assets TTM | 1.01% |
| Return on equity TTM | 9.65% |
| Profit margin | 54.13% |
| Book value | $78.72 |
| Market capitalisation | $63.5 billion |
TTM: trailing 12 months
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like CME Group.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 16.2
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and CME Group's overall score of 16.2 (as at 12/31/2018) is excellent – landing it in it in the 10th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like CME Group is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 6.41/100
CME Group's environmental score of 6.41 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that CME Group is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 9.64/100
CME Group's social score of 9.64 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that CME Group is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 8.65/100
CME Group's governance score puts it squarely in the 5th percentile of companies rated in the same sector. That could suggest that CME Group is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 1/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. CME Group scored a 1 out of 5 for controversy – the highest score possible, reflecting that CME Group has managed to keep its nose clean.
CME Group Inc was last rated for ESG on: 2019-01-01.
| Total ESG score | 16.2 |
|---|---|
| Total ESG percentile | 9.8 |
| Environmental score | 6.41 |
| Environmental score percentile | 5 |
| Social score | 9.64 |
| Social score percentile | 5 |
| Governance score | 8.65 |
| Governance score percentile | 5 |
| Level of controversy | 1 |
Dividend payout ratio: 123.76% of net profits
Recently CME Group has paid out, on average, around 123.76% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 4.84% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), CME Group shareholders could enjoy a 4.84% return on their shares, in the form of dividend payments. In CME Group's case, that would currently equate to about $3.9 per share.
CME Group's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
CME Group's most recent dividend payout was on 17 January 2023. The latest dividend was paid out to all shareholders who bought their shares by 26 December 2022 (the "ex-dividend date").
CME Group's shares were split on a 5:1 basis on 22 July 2012. So if you had owned 1 share the day before before the split, the next day you'd have owned 5 shares. This wouldn't directly have changed the overall worth of your CME Group shares – just the quantity. However, indirectly, the new 80% lower share price could have impacted the market appetite for CME Group shares which in turn could have impacted CME Group's share price.
Over the last 12 months, CME Group's shares have ranged in value from as little as $161.3333 up to $245.2584. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while CME Group's is 0.4046. This would suggest that CME Group's shares are less volatile than average (for this exchange).
CME Group Inc. , together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc.
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Everything we know about the SONDORS IPO, plus information on how to buy in.
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Learn about stock analysis and how to use it to find the right company to buy.